A Randomized, Open-label, Crossover Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg and Immediate Release Formulation After Multiple Dosing Under Fed Condition in Healthy Male Subjects (GLA5PR-102)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by GL Pharm Tech Corporation.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
GL Pharm Tech Corporation
ClinicalTrials.gov Identifier:
NCT01638273
First received: July 9, 2012
Last updated: July 10, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: July 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)